company background image
301126 logo

Hunan Dajiaweikang Pharmaceutical IndustryLtd SZSE:301126 Stock Report

Last Price

CN¥11.21

Market Cap

CN¥2.3b

7D

-2.1%

1Y

-21.4%

Updated

24 Nov, 2024

Data

Company Financials

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

SZSE:301126 Stock Report

Market Cap: CN¥2.3b

301126 Stock Overview

Engages in the wholesale and retail of pharmaceuticals products in China. More details

301126 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health2/6
Dividends1/6

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hunan Dajiaweikang Pharmaceutical IndustryLtd
Historical stock prices
Current Share PriceCN¥11.21
52 Week HighCN¥14.49
52 Week LowCN¥6.61
Beta0.86
11 Month Change-8.86%
3 Month Change29.00%
1 Year Change-21.44%
33 Year Changen/a
5 Year Changen/a
Change since IPO-52.70%

Recent News & Updates

There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump

Oct 08
There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump

Recent updates

There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump

Oct 08
There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump

Optimistic Investors Push Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Shares Up 30% But Growth Is Lacking

May 09
Optimistic Investors Push Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Shares Up 30% But Growth Is Lacking

Market Might Still Lack Some Conviction On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Even After 31% Share Price Boost

Mar 08
Market Might Still Lack Some Conviction On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Even After 31% Share Price Boost

Shareholder Returns

301126CN HealthcareCN Market
7D-2.1%-2.0%-2.1%
1Y-21.4%-17.0%2.8%

Return vs Industry: 301126 underperformed the CN Healthcare industry which returned -17% over the past year.

Return vs Market: 301126 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 301126's price volatile compared to industry and market?
301126 volatility
301126 Average Weekly Movement8.9%
Healthcare Industry Average Movement8.7%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 301126 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 301126's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20023,461Shengli Huwww.djwk.com.cn

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. The company offers anabolic preparations and peptide hormones, second-class psychotropic drugs, vaccines, antibiotic raw materials, biological products, biochemical drugs, antibiotic preparations, Chinese medicine decoction pieces, chemical drug preparations, chemical raw materials, Chinese herbal medicines, Chinese patent medicines, and medical toxic drugs; medical devices; and health food products. It also provides pharmaceutical logistics services; and operates reproductive hospitals.

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Fundamentals Summary

How do Hunan Dajiaweikang Pharmaceutical IndustryLtd's earnings and revenue compare to its market cap?
301126 fundamental statistics
Market capCN¥2.30b
Earnings (TTM)CN¥46.93m
Revenue (TTM)CN¥5.11b

49.1x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301126 income statement (TTM)
RevenueCN¥5.11b
Cost of RevenueCN¥4.16b
Gross ProfitCN¥952.22m
Other ExpensesCN¥905.29m
EarningsCN¥46.93m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.23
Gross Margin18.64%
Net Profit Margin0.92%
Debt/Equity Ratio170.4%

How did 301126 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

17%

Payout Ratio